they only liked reform because they got what they wanted. no competition from a public option, no use of purchasing power to drive down drug costs, & lots of new customers to gouge, subsidized by the taxpayer. Its ironic that the bill may be a boon to the very companies it was supposed to reform. Too bad the public will have no appetite for more democrat reforms when this one utterly fails to contain cost.
|